Marginal Zone Lymphoma (MZL) Clinical Trials in Beijing
2 recruitingBeijing, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
MZL-IPI Risk-adapted Targeted Therapy in Untreated MZL
Marginal Zone Lymphoma (MZL)
Ruijin Hospital145 enrolled3 locationsNCT06793189
Recruiting
Phase 4
Application of Orelabrutinib With or Without CD20 Monoclonal Antibody in Previously Untreated Marginal Zone Lymphoma
Marginal Zone Lymphoma (MZL)
Beijing Tongren Hospital88 enrolled3 locationsNCT07355699